182 related articles for article (PubMed ID: 16271099)
1. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
Benjamin RJ; McCullough J; Mintz PD; Snyder E; Spotnitz WD; Rizzo RJ; Wages D; Lin JS; Wood L; Corash L; Conlan MG
Transfusion; 2005 Nov; 45(11):1739-49. PubMed ID: 16271099
[TBL] [Abstract][Full Text] [Related]
2. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
Brixner V; Kiessling AH; Madlener K; Müller MM; Leibacher J; Dombos S; Weber I; Pfeiffer HU; Geisen C; Schmidt M; Henschler R; North A; Huang N; Mufti N; Erickson A; Ernst C; Rico S; Benjamin RJ; Corash LM; Seifried E
Transfusion; 2018 Apr; 58(4):905-916. PubMed ID: 29498049
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
4. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
Cancelas JA; Dumont LJ; Rugg N; Szczepiorkowski ZM; Herschel L; Siegel A; Pratt PG; Worsham DN; Erickson A; Propst M; North A; Sherman CD; Mufti NA; Reed WF; Corash L
Transfusion; 2011 Nov; 51(11):2367-76. PubMed ID: 21569044
[TBL] [Abstract][Full Text] [Related]
5. Viability of red cells prepared with S-303 pathogen inactivation treatment.
Rios JA; Hambleton J; Viele M; Rugg N; Sindermann G; Greenwalt T; Wages D; Cook D; Corash L
Transfusion; 2006 Oct; 46(10):1778-86. PubMed ID: 17002635
[TBL] [Abstract][Full Text] [Related]
6. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients.
Bennett-Guerrero E; Stafford-Smith M; Waweru PM; Bredehoeft SJ; Campbell ML; Haley NR; Phillips-Bute B; Newman MF; Bandarenko N
Transfusion; 2009 Jul; 49(7):1375-83. PubMed ID: 19389021
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment.
North A; Ciaravino V; Mufti N; Corash L
Transfusion; 2011 Oct; 51(10):2208-18. PubMed ID: 21985050
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
9. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery.
Basran S; Frumento RJ; Cohen A; Lee S; Du Y; Nishanian E; Kaplan HS; Stafford-Smith M; Bennett-Guerrero E
Anesth Analg; 2006 Jul; 103(1):15-20, table of contents. PubMed ID: 16790618
[TBL] [Abstract][Full Text] [Related]
10. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
11. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
12. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
[TBL] [Abstract][Full Text] [Related]
13. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery.
Greenburg AG; Kim HW;
J Am Coll Surg; 2004 Mar; 198(3):373-83; discussion 384-5. PubMed ID: 14992738
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Winter KM; Johnson L; Kwok M; Vidovic D; Hyland RA; Mufti N; Erickson A; Marks DC
Transfusion; 2014 Jul; 54(7):1798-807. PubMed ID: 24617658
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.
Snyder EL; Sekela ME; Welsby IJ; Toyoda Y; Alsammak M; Sodha NR; Beaver TM; Pelletier JPR; Gorham JD; McNeil JS; Sniecinski RM; Pearl RG; Nuttall GA; Sarode R; Reece TB; Kaplan A; Davenport RD; Ipe TS; Benharash P; Lopez-Plaza I; Gammon RR; Sadler P; Pitman JP; Liu K; Bentow S; Corash L; Mufti N; Varrone J; Benjamin RJ;
Trials; 2023 Dec; 24(1):799. PubMed ID: 38082326
[TBL] [Abstract][Full Text] [Related]
16. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design.
Fergusson D; Hutton B; Hogan DL; LeBel L; Blajchman MA; Ford JC; Hebert P; Kakadekar A; Kovacs L; Lee S; Sankaran K; Shapiro S; Smyth JA; Ramesh K; Bouali NR; Tinmouth A; Walker R
Transfus Med Rev; 2009 Jan; 23(1):55-61. PubMed ID: 19056034
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery.
Sanders J; Patel S; Cooper J; Berryman J; Farrar D; Mythen M; Montgomery HE
Transfusion; 2011 Nov; 51(11):2286-94. PubMed ID: 21564106
[TBL] [Abstract][Full Text] [Related]
18. Age of transfused red cells and early outcomes after cardiac surgery.
Yap CH; Lau L; Krishnaswamy M; Gaskell M; Yii M
Ann Thorac Surg; 2008 Aug; 86(2):554-9. PubMed ID: 18640333
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
